Expand RANI Menu
RANI MENU

RANI Latest Press Releases

-- September 8, 2026 --

Rani Therapeutics to Participate in Upcoming September Conferences Globe Newswire 8:00 AM

-- August 13, 2026 --

Rani Therapeutics Reports Second Quarter 2026 Financial Results; Provides Corporate Update Globe Newswire 4:05 PM

-- August 10, 2026 --

Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference Globe Newswire 8:00 AM

-- August 4, 2026 --

Rani Therapeutics Appoints Michelle Gilson to Board of Directors Globe Newswire 8:00 AM

-- July 20, 2026 --

Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- July 15, 2026 --

Rani Therapeutics Announces Positive Initial Phase 1a Data for RT-114 for the Treatment of Obesity, with Oral Bioavailability Exceeding Matched Subcutaneous Dosing Globe Newswire 8:00 AM

-- July 9, 2026 --

Rani Therapeutics Announces Research and Development Collaboration with PegBio to Expand Obesity Pipeline Across Multiple Novel Candidates Globe Newswire 4:05 PM

-- June 29, 2026 --

Rani Therapeutics Appoints Nicholas Maestas as Chief Financial Officer Globe Newswire 8:00 AM

-- May 26, 2026 --

Rani Therapeutics Holdings, Inc. Announces Pricing of $20.0 Million Registered Direct Offering of Class A Common Stock Priced At-The-Market Under Nasdaq Rules Globe Newswire 8:00 AM

-- May 15, 2026 --

Rani Therapeutics Reports First Quarter 2026 Financial Results; Provides Corporate Update; Announces CFO Transition Globe Newswire 4:05 PM

-- May 12, 2026 --

Rani Therapeutics to Participate in the H.C. Wainwright Annual BioConnect Investor Conference Globe Newswire 4:05 PM
Market Data Delayed 15 Minutes